# Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria

> **NCT01877239** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 111 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** non-intervention

## Key facts

- **NCT ID:** NCT01877239
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-10
- **Primary completion:** 2016-01-07
- **Final completion:** 2016-06-14
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2018-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01877239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01877239, "Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01877239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*